An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

BACKGROUND: Type 1 diabetes is a chronic autoimmune disease that leads to destruction of insulin-producing beta cells and dependence on exogenous insulin for survival. Some interventions have delayed the loss of insulin production in patients with type 1 diabetes, but interventions that might affect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Herold, Kevan C., Bundy, Brian N., Long, S. Alice, Bluestone, Jeffrey A., DiMeglio, Linda A., Dufort, Matthew J., Gitelman, Stephen E., Gottlieb, Peter A., Krischer, Jeffrey P., Linsley, Peter S., Marks, Jennifer B., Moore, Wayne, Moran, Antoinette, Rodriguez, Henry, Russell, William E., Schatz, Desmond, Skyler, Jay S., Tsalikian, Eva, Wherrett, Diane K., Ziegler, Anette-Gabriele, Greenbaum, Carla J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776880/
https://ncbi.nlm.nih.gov/pubmed/31180194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1902226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados